ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
NCT ID: NCT00466063
Last Updated: 2015-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
108 participants
OBSERVATIONAL
2007-05-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICL670
ICL670
Deferasirox
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deferasirox
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of iron overload
Exclusion Criteria
2 Years
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Alabama Medical Center
Mobile, Alabama, United States
Children's Hospital Los Angeles
Los Angeles, California, United States
Children's Hospital Oakland
Oakland, California, United States
Children's Hospital of Orange County
Orange, California, United States
Stanford University Medical Center
Stanford, California, United States
MD Anderson Cancer Center - Orlando
Orlando, Florida, United States
St. Joseph's Children's Hospital of Tampa
Tampa, Florida, United States
Children's Memorial Hospital
Chicago, Illinois, United States
Children's Hospital Boston
Boston, Massachusetts, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
St. Joseph's Children's Hospital
Paterson, New Jersey, United States
The Brooklyn Hospital Center
Brooklyn, New York, United States
Schneider Children's Hospital
New York, New York, United States
SUNY - Upstate Medical University
Syracuse, New York, United States
East Carolina University
Greenville, North Carolina, United States
Akron Children's Hospital
Akron, Ohio, United States
Children's Medical Center
Dayton, Ohio, United States
Oklahoma State University Health Sciences Center
Oklahoma City, Oklahoma, United States
Penn State University / Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
St. Jude Children's Research Hospital Memphis
Memphis, Tennessee, United States
Cook's Children's Medical Center
Fort Worth, Texas, United States
Texas Children's Hospital
Houston, Texas, United States
Children's Hospital of the King's Daughters
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CICL670A2411
Identifier Type: -
Identifier Source: org_study_id